MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
MSI-H or dMMR Stage IV Colorectal Carcinoma (after progression of First and second line Standard Therapy)
3Phase III in Spain, 2Phase II in Spain, 1Phase I